Literature DB >> 29419709

Efficacy of a Clinic-Based Safer Sex Program for Human Immunodeficiency Virus-Uninfected and Human Immunodeficiency Virus-Infected Young Black Men Who Have Sex With Men: A Randomized Controlled Trial.

Richard A Crosby, Leandro Mena, Laura F Salazar, James W Hardin, Tim Brown, Rachel Vickers Smith.   

Abstract

OBJECTIVE: To test the efficacy of a single-session, clinic-based intervention designed to promote condom use among young black men who have sex with men (YBMSM).
METHODS: Six hundred YBMSM were enrolled in a randomized controlled trial, using a 12-month observation period. An intent-to-treat analysis was performed, with multiple imputation for missing data.
RESULTS: Compared with the reference group, human immunodeficiency virus (HIV)-infected men in the intervention group had 64% greater odds of reporting consistent condom use for anal receptive sex over 12 months (estimated odds ratio, 1.64; 95% confidence interval, 1.23-2.17, P = 0.001). Also, compared with the reference group, HIV-uninfected men in the intervention group had more than twice the odds of reporting consistent condom use for anal receptive sex over 12 months (estimated odds ratio, 2.14; 95% confidence interval, 1.74-2.63, P < 0.001). Significant intervention effects relative to incident sexually transmitted diseases were not observed.
CONCLUSIONS: A single-session, clinic-based, intervention may help protect HIV-uninfected YBMSM against HIV acquisition and HIV-infected YBMSM from transmitting the virus to insertive partners.

Entities:  

Mesh:

Year:  2018        PMID: 29419709     DOI: 10.1097/OLQ.0000000000000721

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  7 in total

1.  Condom use intentions mediate the relationships between psychosocial constructs and HIV sexual risk behavior in young Black men who have sex with men.

Authors:  Seul Ki Choi; Sara LeGrand; Willa Dong; Kathryn E Muessig; Lisa Hightow-Weidman
Journal:  AIDS Care       Date:  2018-06-27

2.  Brothers Building Brothers by Breaking Barriers: development of a resilience-building social capital intervention for young black gay and bisexual men living with HIV.

Authors:  Sophia A Hussen; Marxavian Jones; Shamia Moore; Jasper Hood; Justin C Smith; Andres Camacho-Gonzalez; Carlos Del Rio; Gary W Harper
Journal:  AIDS Care       Date:  2019-01-09

3.  Sexually transmitted infections and sexual behaviors of men who have sex with men in an American Deep South PrEP clinic.

Authors:  Ronnie M Gravett; Andrew O Westfall; Edgar T Overton; Kachina Kudroff; Christina A Muzny; Ellen F Eaton
Journal:  Int J STD AIDS       Date:  2020-01-28       Impact factor: 1.359

4.  Effectiveness of interventions aimed at reducing HIV acquisition and transmission among gay and bisexual men who have sex with men (GBMSM) in high income settings: A systematic review.

Authors:  Janey Sewell; Ibidun Fakoya; Fiona C Lampe; Alison Howarth; Andrew Phillips; Fiona Burns; Alison J Rodger; Valentina Cambiano
Journal:  PLoS One       Date:  2022-10-19       Impact factor: 3.752

5.  Foretelling the Future: Predicting STI Diagnosis and Its Implications for Ending the HIV Epidemic among Black Men Who Have Sex with Men.

Authors:  Paul A Burns; Leandro A Mena; Richard L Crosby
Journal:  J Urban Health       Date:  2020-10       Impact factor: 3.671

6.  A Person-Centered Approach to HIV-Related Protective and Risk Factors for Young Black Men Who Have Sex with Men: Implications for Pre-exposure Prophylaxis and HIV Treatment as Prevention.

Authors:  Wilson Vincent; John L Peterson; Erik D Storholm; David M Huebner; Torsten B Neilands; Sarah K Calabrese; Gregory M Rebchook; Judy Y Tan; Lance Pollack; Susan M Kegeles
Journal:  AIDS Behav       Date:  2019-10

7.  What is the added value of incorporating pleasure in sexual health interventions? A systematic review and meta-analysis.

Authors:  Mirela Zaneva; Anne Philpott; Arushi Singh; Gerda Larsson; Lianne Gonsalves
Journal:  PLoS One       Date:  2022-02-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.